SCHEMBL12373489

SCHEMBL12373489

CCn1c(C(C)NS(=O)(=O)c2ccc(OC)c(OC)c2)cnc1Oc1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 2/20 0.43
NPSR1 Q6W5P4 1/20 0.42
S1PR1 P21453 5/20 0.42
S1PR3 Q99500 1/20 0.42
TRIM24 O15164 2/20 0.40
BRD1 O95696 2/20 0.40
BRPF1 P55201 2/20 0.40
BRPF3 Q9ULD4 1/20 0.40
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
FFAR4 Q5NUL3 1/20 0.39
CNR1 P21554 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12373517 0.90 S1PR1 (0.44) ALDH1A1TSHRKMT2AS1PR1S1PR3
SCHEMBL4119410 0.89 CNR1 (0.47) ALDH1A1S1PR1S1PR3TRIM24BRPF1
SCHEMBL12373690 0.89 S1PR1 (0.41) S1PR1S1PR3TRIM24BRD1BRPF1
SCHEMBL12373568 0.88 POLB (0.44) ALDH1A1TSHRKMT2AMEN1
SCHEMBL12373648 0.87 S1PR1 (0.40) S1PR1S1PR3CNR1
SCHEMBL12373619 0.87 S1PR1 (0.48) S1PR1S1PR3CNR1
SCHEMBL12373503 0.87 CYSLTR1 (0.43) ALDH1A1S1PR1S1PR3
SCHEMBL12373587 0.87 SMN1; SMN2 (0.46) LMNAALDH1A1KMT2AMEN1CNR1
SCHEMBL12373552 0.87 PGR (0.44) ALDH1A1TSHRS1PR1S1PR3TRIM24
SCHEMBL12373566 0.87 S1PR1 (0.40) ALDH1A1S1PR1S1PR3CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994204-B2 Binding inhibitor of sphingosine-1-phosphate TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-08-09 US disclosed
US-7994204-B2 Binding inhibitor of sphingosine-1-phosphate TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-08-09 US disclosed
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-16 US disclosed
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE S1PR1, S1PR3, S1PR2 LMNA 3437/4885HTT 4589/4885ALDH1A1 2969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.